VKTX vs. SDGR

In the year-to-date period, VKTX achieves a -33.40% return, which is significantly lower than SDGR's 12.08% return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Viking Therapeutics, Inc. (VKTX) and Schrodinger, Inc. (SDGR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current VKTX Sharpe Ratio is -0.68, which is lower than the SDGR Sharpe Ratio of -0.01. The chart below compares the historical Sharpe Ratios of VKTX and SDGR, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Neither VKTX nor SDGR has paid dividends to shareholders.

The maximum VKTX drawdown since its inception was -90.41%, which is greater than SDGR's maximum drawdown of -85.64%. Use the drawdown chart below to compare losses from any high point for VKTX and SDGR.

Viking Therapeutics, Inc. (VKTX) and Schrodinger, Inc. (SDGR) have volatilities of 16.04% and 15.56%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Viking Therapeutics, Inc. and Schrodinger, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.